RAPID MICRO BIOSYSTEMS, INC.
RPIDNasdaq
$2.07
↓ -1.0%Jul 17 close · end-of-day
Price
1Y↓ -36.9%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$94.0M
Enterprise Value
$90.2M
P/E
—
P/S
2.7
P/B
4.6
EV/EBITDA
—
PEG
—
FCF Yield
-40.4%
Dividend Yield
—
Revenue (TTM)
$34.4M
Net Income (TTM)
-$50.1M
Free Cash Flow (TTM)
-$38.0M
Gross Margin
—
Operating Margin
-144.2%
Net Margin
-145.8%
ROE
-245.8%
ROIC
-237.4%
Debt / Equity
0.9
Net Cash
$3.9M
Return 1Y
-40.0%
Company profile
Rapid Micro Biosystems, Inc. provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services.
- CEO
- Robert Spignesi
- Sector
- Manufacturing
- Industry
- Measuring And Control Equipment
- Employees
- 200
- Headquarters
- Massachusetts
- Website
- rapidmicrobio.com
Management & directors
- Spignesi Robert G. Jr.PRESIDENT AND CEO
- Wirtjes Sean MCHIEF FINANCIAL OFFICER
- Wilson John J. AddingtonCHIEF OPERATING OFFICER
Roles derived from SEC Form 4 filings.
Earnings
RPID Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$8.0M↑ +11.1%
Diluted EPS-$0.31↑ +19.2%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $16.1M | $23.2M | $17.1M | $22.5M | $28.1M | $33.6M |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$30.5M | -$47.2M | -$63.2M | -$56.6M | -$49.9M | -$47.4M |
| Net income | -$37.1M | -$73.5M | -$60.8M | -$52.5M | -$46.9M | -$47.1M |
| Diluted EPS | -$126.11 | -$3.94 | -$1.43 | -$1.22 | -$1.08 | -$1.05 |
| Operating cash flow | -$31.0M | -$55.0M | -$58.5M | -$45.1M | -$44.2M | -$31.1M |
| Free cash flow | -$31.7M | -$58.2M | -$65.3M | -$46.9M | -$45.5M | -$31.9M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -190.0% | -203.3% | -369.0% | -251.2% | -178.0% | -141.1% |
| Net margin | -230.6% | -316.5% | -354.9% | -233.0% | -167.2% | -140.3% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.6M | $7.6M | $8.2M | $7.2M | $7.3M | $7.8M | $11.3M | $8.0M |
| Gross profit | — | — | — | $404,000.00 | — | — | — | $371,000.00 |
| Operating income | -$13.4M | -$12.0M | -$10.2M | -$11.7M | -$12.1M | -$11.4M | -$12.2M | -$13.9M |
| Net income | -$12.6M | -$11.3M | -$9.7M | -$11.3M | -$11.9M | -$11.5M | -$12.5M | -$14.3M |
| Diluted EPS | -$0.29 | -$0.26 | -$0.22 | -$0.26 | -$0.27 | -$0.26 | -$0.26 | -$0.31 |
| Operating cash flow | -$10.1M | -$8.6M | -$9.9M | -$9.1M | -$9.7M | -$9.1M | -$3.2M | -$15.1M |
| Free cash flow | -$10.6M | -$8.8M | -$10.0M | -$9.4M | -$10.1M | -$9.1M | -$3.3M | -$15.5M |
| Gross margin | — | — | — | 5.6% | — | — | — | 4.6% |
| Operating margin | -202.1% | -158.3% | -124.5% | -161.8% | -167.3% | -145.1% | -108.2% | -173.1% |
| Net margin | -190.1% | -148.9% | -117.6% | -156.3% | -163.3% | -146.8% | -110.8% | -178.4% |
Company news
May 14, 2026
May 13, 2026
- 68d agoRapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimatesfinance.yahoo.com
- 68d agoClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimatesfinance.yahoo.com
- 68d agoRapid Micro Biosystems Q1 2026 Earnings Call: Complete Transcriptfinance.yahoo.com
- 68d agoRapid Micro Biosystems Reports First Quarter 2026 Financial Resultsfinance.yahoo.com
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-29 | LOWENSTEIN INESE | Award | 12,787 | $1.96 | $24,998.59 | filing |
| 2026-05-29 | PEI MELINDA LITHERLAND | Award | 12,787 | $1.96 | $24,998.59 | filing |
| 2026-05-29 | Malloy Kirk | Award | 12,787 | $1.96 | $24,998.59 | filing |
| 2026-05-29 | WIRTJES SEAN M· CHIEF FINANCIAL OFFICER | Award | 12,787 | $1.96 | $24,998.59 | filing |
| 2026-05-29 | Spignesi Robert G. Jr.· PRESIDENT AND CEO | Award | 12,787 | $1.96 | $24,998.59 | filing |
| 2026-05-21 | Malloy Kirk | Award | 19,300 | $0.00 | $0.00 | filing |
| 2026-05-21 | LOWENSTEIN INESE | Award | 19,300 | $0.00 | $0.00 | filing |
| 2026-05-21 | PEI MELINDA LITHERLAND | Award | 19,300 | $0.00 | $0.00 | filing |
| 2026-05-21 | Kollender Richard S | Award | 19,300 | $0.00 | $0.00 | filing |
| 2026-05-21 | Bika Dafni | Award | 19,300 | $0.00 | $0.00 | filing |
| 2026-03-11 | Wilson John J. Addington· CHIEF OPERATING OFFICER | Sale | 9,603 | $4.32 | $41,466.71 | filing |
| 2026-03-11 | WIRTJES SEAN M· CHIEF FINANCIAL OFFICER | Sale | 7,480 | $4.32 | $32,299.39 | filing |
| 2026-03-10 | Spignesi Robert G. Jr.· PRESIDENT AND CEO | Sale | 17,922 | $4.11 | $73,686.30 | filing |
| 2026-02-27 | RICCIARDI NATALE S | Option exercise | 842 | $0.75 | $631.50 | filing |
| 2026-02-20 | WIRTJES SEAN M· CHIEF FINANCIAL OFFICER | Sale | 17,254 | $3.92 | $67,687.44 | filing |
| 2026-02-20 | Wilson John J. Addington· CHIEF OPERATING OFFICER | Sale | 5,403 | $3.92 | $21,195.97 | filing |
| 2026-02-19 | Spignesi Robert G. Jr.· PRESIDENT AND CEO | Sale | 38,327 | $3.89 | $148,911.89 | filing |
| 2026-02-11 | Wilson John J. Addington· CHIEF OPERATING OFFICER | Award | 74,000 | $0.00 | $0.00 | filing |
| 2026-02-11 | WIRTJES SEAN M· CHIEF FINANCIAL OFFICER | Award | 97,000 | $0.00 | $0.00 | filing |
| 2026-02-11 | Spignesi Robert G. Jr.· PRESIDENT AND CEO | Award | 264,000 | $0.00 | $0.00 | filing |
| 2026-02-09 | Spignesi Robert G. Jr.· PRESIDENT AND CEO | Sale | 12,840 | $3.78 | $48,569.87 | filing |
| 2026-02-09 | WIRTJES SEAN M· CHIEF FINANCIAL OFFICER | Sale | 6,027 | $3.78 | $22,798.33 | filing |
| 2026-02-09 | Wilson John J. Addington· CHIEF OPERATING OFFICER | Sale | 4,610 | $3.78 | $17,438.25 | filing |
| 2026-02-04 | Longitude Capital Partners II, LLC | Sale | 49,000 | $3.88 | $190,090.60 | filing |
| 2026-02-03 | Longitude Capital Partners II, LLC | Sale | 27,500 | $4.24 | $116,641.25 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.